Skip to main content

Table 1 Study sample demographic characteristics

From: Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy

 

Study sample, n = 91 n (%)

Non-responders, n = 41 n (%)

Male

73 (82)

36 (86)

Insurance

  

Medicaid

52 (57)

27 (66)

Uninsured

23 (25)

8 (20)

Medicare

10 (11)

0 (0)

Private

9 (10)

6 (15)

Race/Ethnicity

  

Caucasian

38 (42)

12 (29)

African-American

34 (37)

17 (42)

Hispanic

18 (20)

12 (29)

Asian

1 (1)

0 (0)

Buprenorphine treatment history

  

Median buprenorphine dose, (range)

20 mg/day (1.5, 24)

16 mg/day (1, 24)

Mean time in treatment (months), (range)

28 (1, 71)

32 (1, 75)